U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H16N2O
Molecular Weight 240.3003
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PICOBENZIDE

SMILES

CC1=CC(=CC(C)=C1)C(=O)NCC2=CC=NC=C2

InChI

InChIKey=JROSDBYIFZWPBP-UHFFFAOYSA-N
InChI=1S/C15H16N2O/c1-11-7-12(2)9-14(8-11)15(18)17-10-13-3-5-16-6-4-13/h3-9H,10H2,1-2H3,(H,17,18)

HIDE SMILES / InChI
Picobenzide is a synthetic product which is of therapeutic interest owing to its neuroleptic, anti-inflammatory and spasmolytic action and because its properties are similar to those of the phenotiazines. The product is largely metabolized into the N-oxide form and is also partially eliminated in urine in an unaltered state.

Approval Year

PubMed

PubMed

TitleDatePubMed
[Comparative study of the pharmacological activity of N-(4-picolyl)-3,5-dimethylbenzamide (M-14012-4) and its N-oxide metabolite (M-3312-4). New pharmacological aspects].
1979 Dec
[Effect of N-(4-picolyl)-3,5 dimethylbenzamide on arterial pressure and heart rate in unanesthetized rats].
1981 Apr
[Effect of N-(4-picolyl)-3,5 dimethylbenzamide (M-14012-4) on stereotyped behavior induced by apomorphine and amphetamine in the rat and mouse].
1981 Apr
[Modification of the triphasic mortality curve of d-amphetamine].
1982 Dec
[Comparative study of the central effects of M-14012-A and SKF-525-A in rodents].
1983 Aug
Determination of N-oxide of picobenzide by differential pulse polarography.
1983 Oct
[Effect of MA-14012 (Dosetil) on lymphocyte mitogenesis. In vitro study].
1984 Jan-Feb
A dopaminergic receptor modulates catecholamine release from the cat adrenal gland.
1985 May
Pharmacokinetics and initial distribution of a new neuroleptic agent picobenzide (M-14012-4).
1985 May
'In vitro' metabolism of N-picolyl-3,5-dimethylbenzamides.
1986 Apr-Jun
Isolation and identification of the N-oxide metabolite of picobenzide in human urine.
1986 Jan-Mar
Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide.
1989 Jan-Mar
Synthesis and biological activity of picobenzide (3,5-dimethyl-N-(pyridin-4-ylmethyl)benzamide) analogues as potential antipsychotic agents.
2005

Sample Use Guides

Single dose - 10 mg/kg
Route of Administration: Intravenous
Name Type Language
PICOBENZIDE
INN  
INN  
Official Name English
3,5-DIMETHYL-N-(4-PYRIDYLMETHYL)BENZAMIDE
Systematic Name English
picobenzide [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29710
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
Code System Code Type Description
MESH
C016938
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
PUBCHEM
40146
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
SMS_ID
100000081919
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
ChEMBL
CHEMBL1581974
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
NCI_THESAURUS
C76443
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
INN
4674
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
EPA CompTox
DTXSID10199792
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
EVMPD
SUB09814MIG
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
FDA UNII
C46317G8F0
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY
CAS
51832-87-2
Created by admin on Fri Dec 15 16:09:57 GMT 2023 , Edited by admin on Fri Dec 15 16:09:57 GMT 2023
PRIMARY